FindTrial
Sign In

Effect of Pranayama on movement of chest wall, respiratory muscle and lung function in patients with lung disease

Influence of Pranayama breathing techniques on thoracic cage biomechanics, respiratory muscle activity and lung function in patients with chronic respiratory disease: A randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048897
Enrollment
52
Registered
2023-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J80- Acute respiratory distress syndrome Health Condition 2: J630- Aluminosis (of lung) Health Condition 3: J631- Bauxite fibrosis (of lung) Health Condition 4: J632- Berylliosis Health Condition 5: J470- Bronchiectasis with acute lower respiratory infection Health Condition 6: J479- Bronchiectasis, uncomplicated Health Condition 7: J40- Bronchitis, not specified as acuteor chronic Health Condition 8: J660- Byssinosis Health Condition 9: J432- Centrilobular emphysema Health C

Interventions

Intervention1: Experimental Group: A 5 days/week program with 2 supervised sessions for 12 weeks and each session for 20-30 minutes. It includes Pranayam intervention with one set of Anulom Vilom, Bhr

Sponsors

MGM School of Physiotherapy, MGM Institute of Health Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Any stable chronic respiratory diseases over 4 weeks (ICD 10 Classification- Bronchitis (J40-42), Emphysema (J43), other COPD (J44), Asthma (J45-46), Bronchiectasis (J47), Pneumoconiosis (J60-70), Adult respiratory distress syndrome (J80), Idiopathic Pulmonary Fibrosis (J84) ii. Age group of 18- 75 years both male and female iii. Mild to severe obstructions with GOLD grade 1-3, post bronchodilator FEV1/FVC 0.7 for restrictive conditions

Exclusion criteria

Exclusion criteria: i. Recent exacerbation of the disease ii. Associated cardiac, psychological, neurological disorders iii. BMI >35 kg/m2 iv. Thoracic cage abnormalities like scoliosis, kyphosis, recent trauma, fractures of ribs

Design outcomes

Primary

MeasureTime frame
•Kinematics of the thorax using 3D motion-capture system •Pulmonary lung functions will measure the forced vital capacity, forced expiratory volume, at 1 second maximum inspiratory pressure, maximum expiratory •Respiratory muscle activity assessment using surface EMG •Assess the cardiovascular endurance using six-minute walk test Timepoint: Pre intervention, at the 6th week of intervention, at the 12th week of intervention—

Secondary

MeasureTime frame
NoneTimepoint: None—

Countries

India

Contacts

Public ContactBela Agarwal

MGM School of Physiotherapy, MGM Institute of Health Sciences

bagarwal@mgmsopnm.edu.in981900064

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026